Abstract
This study investigates the therapeutic potential of emodin, a natural compound derived from traditional Chinese medicine, against human pancreatic cancer (Panc-1 cells). Through both in vitro and in vivo experiments, we demonstrate that emodin inhibits cell proliferation and induces apoptosis by triggering a decline in mitochondrial membrane potential (MMP). Our findings suggest that a moderate dose of emodin effectively reduces tumor growth while maintaining the overall health of the subject, offering a promising alternative or adjunct to current chemotherapy.
Introduction
Pancreatic cancer remains a significant clinical challenge due to its high mortality rate and limited response to standard treatments like gemcitabine. The search for more effective and less toxic compounds has led to the investigation of emodin (1,3,8-trihydroxyl-6-methyl anthraquinone). While its anti-cancer properties have been noted in other malignancies, its specific impact on pancreatic cancer—particularly the role of mitochondrial pathways—requires detailed exploration.
Methods
Human Panc-1 cells were treated with emodin concentrations ranging from 0 to 80 µmol/l. Cell proliferation was assessed via MTT assay, while apoptosis and mitochondrial membrane potential (MMP) were analyzed using flow cytometry (Annexin V/PI staining) and JC-1 staining, respectively. For in vivo studies, nude mice with orthotopically implanted Panc-1 tumors were treated with varying doses of emodin (10–80 mg/kg) via intraperitoneal injection. Tumor size, body weight, and appetite (feeding stuff intake) were monitored.
Results
Inhibition of Cell Proliferation
Emodin exhibited a clear dose- and time-dependent inhibitory effect on Panc-1 cell proliferation. In vitro results showed that 40 µmol/l of emodin inhibited growth by approximately 54.7% after 72 hours.
Induction of Apoptosis
Flow cytometric analysis revealed a significant increase in the apoptotic rate of Panc-1 cells as emodin concentration increased. This was further confirmed in vivo through TUNEL assays of tumor tissues.
Mechanism: Decline in Mitochondrial Membrane Potential (MMP)
The primary mechanism of emodin-induced apoptosis appears to be the disruption of mitochondrial integrity. JC-1 staining showed a shift from red fluorescence (healthy mitochondria) to green fluorescence (cytoplasmic monomers), indicating a significant decline in MMP. This dissipation of membrane potential triggers the release of pro-apoptotic factors into the cytoplasm.
In Vivo Efficacy and Safety
In the orthotopic mouse model, emodin treatment significantly reduced tumor diameters compared to the control group. Notably, the study identified a therapeutic "sweet spot": while the highest dose (E80) was effective, it caused a sharp decline in appetite. The E40 group (40 mg/kg) achieved high apoptosis rates without significantly compromising the mice's feeding behavior or overall living state.
Conclusion
Emodin induces apoptosis in pancreatic cancer cells by destabilizing the mitochondrial membrane potential. Its ability to inhibit tumor growth at moderate doses without severe systemic toxicity makes it a compelling candidate for further clinical development in the treatment of pancreatic cancer.
Summary updated